Biologic and targeted synthetic disease‐modifying anti‐rheumatic drugs improve body composition in rheumatoid arthritis patients more than conventional synthetic disease‐modifying anti‐rheumatic drugs: Results from the <scp>PRESENT</scp> study
Weight and muscle mass increased significantly more with b/tsDMARD than with csDMARD treatment. There were no differences in body composition changes by mode of action with b/tsDMARDs.
Authors
- Midori Goto
- K. Mamoto (ORCID: https://orcid.org/0000-0002-7541-3745)
- Yoshinari Matsumoto (ORCID: https://orcid.org/0000-0002-7896-3101)
- Tatsuya Koike (ORCID: https://orcid.org/0000-0002-1522-8740)
- Takahiro Iida (ORCID: https://orcid.org/0009-0004-0374-9399)
- S. Anno (ORCID: https://orcid.org/0000-0002-7439-0721)
- Masahiro Tada (ORCID: https://orcid.org/0000-0003-3161-3929)
- Tomoyuki Nakamura (ORCID: https://orcid.org/0000-0002-8017-9818)
- Noriaki Hidaka (ORCID: https://orcid.org/0000-0002-3484-9809)
Institutions
- Osaka City General Hospital (JP)
- Yodogawa Christian Hospital (JP)
- Osaka Metropolitan University (JP)
Publication Details
- Journal
- International Journal of Rheumatic Diseases
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1111/1756-185x.15371
- Citations
- 4
- Primary Topic
- Autoimmune and Inflammatory Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 1.82